Intraperitoneal chemotherapy for women with epithelial ovarian cancer

Edward L. Trimble, Sharon Thompson, Michaele C. Christian, Lori Minasian

Research output: Contribution to journalReview article

Abstract

In 2006, i.p. chemotherapy re-emerged as a controversial topic in debates about the optimal treatment for women with advanced epithelial ovarian cancer. In this paper, we address the rationale behind i.p. chemotherapy, the data supporting its use, the selection of appropriate patients for i.p. chemotherapy, how best to avoid and manage the toxicities observed with i.p. chemotherapy, and directions for future research.

Original languageEnglish (US)
Pages (from-to)403-409
Number of pages7
JournalOncologist
Volume13
Issue number4
DOIs
StatePublished - Apr 1 2008

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Intraperitoneal chemotherapy for women with epithelial ovarian cancer'. Together they form a unique fingerprint.

  • Cite this